HK1190942A1 - 用於刺激免疫反應的產品和方法 - Google Patents

用於刺激免疫反應的產品和方法

Info

Publication number
HK1190942A1
HK1190942A1 HK14104252.9A HK14104252A HK1190942A1 HK 1190942 A1 HK1190942 A1 HK 1190942A1 HK 14104252 A HK14104252 A HK 14104252A HK 1190942 A1 HK1190942 A1 HK 1190942A1
Authority
HK
Hong Kong
Prior art keywords
stimulating
products
methods
immune response
immune
Prior art date
Application number
HK14104252.9A
Other languages
English (en)
Inventor
Facundo Batista
Julia Eckl-Dorna
Patricia Barral
Vincenzo Cerundolo
Original Assignee
Blink Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Blink Therapeutics Ltd filed Critical Blink Therapeutics Ltd
Publication of HK1190942A1 publication Critical patent/HK1190942A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK14104252.9A 2008-05-02 2014-05-05 用於刺激免疫反應的產品和方法 HK1190942A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4981408P 2008-05-02 2008-05-02

Publications (1)

Publication Number Publication Date
HK1190942A1 true HK1190942A1 (zh) 2014-07-18

Family

ID=40888253

Family Applications (3)

Application Number Title Priority Date Filing Date
HK12101706.9A HK1161542A1 (zh) 2008-05-02 2012-02-21 用於刺激免疫反應的產品和方法
HK14104252.9A HK1190942A1 (zh) 2008-05-02 2014-05-05 用於刺激免疫反應的產品和方法
HK14104596.4A HK1191548A1 (zh) 2008-05-02 2014-05-15 用於刺激免疫反應的產品和方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK12101706.9A HK1161542A1 (zh) 2008-05-02 2012-02-21 用於刺激免疫反應的產品和方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK14104596.4A HK1191548A1 (zh) 2008-05-02 2014-05-15 用於刺激免疫反應的產品和方法

Country Status (9)

Country Link
US (1) US20110280930A1 (zh)
EP (3) EP2288381A2 (zh)
JP (3) JP5721620B2 (zh)
CN (1) CN102170903B (zh)
AU (1) AU2009241645B2 (zh)
CA (1) CA2723226A1 (zh)
ES (1) ES2570973T3 (zh)
HK (3) HK1161542A1 (zh)
WO (1) WO2009133378A2 (zh)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2288381A2 (en) * 2008-05-02 2011-03-02 Cancer Research Technology Limited Products and methods for stimulating an immune response
EP2654779B1 (en) 2010-12-23 2018-02-28 Ludwig Institute for Cancer Research, Ltd. Liposomal formulation of nonglycosidic ceramides and uses thereof
WO2014133106A1 (ja) * 2013-02-27 2014-09-04 独立行政法人理化学研究所 アレルギー疾患治療薬
GB2514591A (en) 2013-05-30 2014-12-03 Mologen Ag Predictive biomarker for cancer therapy
US10894963B2 (en) 2013-07-25 2021-01-19 Exicure, Inc. Spherical nucleic acid-based constructs as immunostimulatory agents for prophylactic and therapeutic use
WO2015021390A2 (en) 2013-08-08 2015-02-12 The Regents Of The University Of California Nanoparticles leverage biological membranes to target pathogens for disease treatment and diagnosis
WO2015084677A1 (en) * 2013-12-02 2015-06-11 Arytha Biosciences, Llc Toxoid preparation and uses thereof
US10098839B2 (en) 2014-03-20 2018-10-16 The Regents Of The University Of California Hydrogel toxin-absorbing or binding nanoparticles
US10434064B2 (en) 2014-06-04 2019-10-08 Exicure, Inc. Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications
CN107708756A (zh) * 2015-04-10 2018-02-16 哈佛学院院长等 免疫细胞捕获装置及其制备和使用方法
CN107530285B (zh) 2015-04-29 2021-07-27 加利福尼亚大学董事会 使用纳米粒子解毒
CN107708740A (zh) * 2015-06-10 2018-02-16 萨尔布吕肯大学 用于治疗b细胞恶性肿瘤的手段和方法
CN115487351A (zh) 2016-02-06 2022-12-20 哈佛学院校长同事会 重塑造血巢以重建免疫
WO2017211314A1 (en) 2016-06-08 2017-12-14 Kei International Limited Method for detecting presence of mycobacterial material in sample using immobilised mannosyl phosphoketide antigen
NL2017204B1 (en) 2016-06-08 2017-12-18 Kei International Ltd Solid substrate comprising antigens immobilised thereto, biosensor comprising said solid substrate and method for detecting the presence of mycobacterial material in a sample
EP3484448A4 (en) 2016-07-13 2020-04-01 President and Fellows of Harvard College MIMETIC SCAFFOLDS OF CELLS HAVING ANTIGEN AND METHODS OF PREPARING AND USING THEM
KR20190086431A (ko) * 2016-08-17 2019-07-22 오르비스 헬스 솔루션즈 엘엘씨 종양-표적화 비드 벡터 및 그의 사용 방법
WO2019032862A1 (en) * 2017-08-10 2019-02-14 Dana-Farber Cancer Institute, Inc. CELLS EXPRESSING LMP1 AND METHODS OF USE
EP3650466A1 (en) * 2018-11-12 2020-05-13 Consejo Superior De Investigaciones Científicas In vitro production of high affinity monoclonal antibodies
CN111229023B (zh) * 2018-11-29 2022-01-28 内蒙古东盛硅藻土科技创新产业园有限公司 一种化学降解添加剂
CN112300987B (zh) * 2020-10-16 2022-04-29 中国农业大学 单个浆细胞的筛选方法及其在小分子单克隆抗体制备中的应用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK590288D0 (da) 1988-10-24 1988-10-24 Symbicom Ab Kemiske forbindelser
AU7058691A (en) 1989-12-22 1991-07-24 Mikrogen Molekularbiologische Entwicklungs-Gmbh Immunologically active proteines from borrelia burgdorferi, related test kits and vaccine
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
DK0571538T5 (da) 1991-02-15 2002-03-04 Uab Research Foundation Strukturgen for pneumokokprotein
DE69229476T2 (de) 1991-08-15 2000-03-16 Smithkline Beecham Biolog Ospa proteine von borrelia burgdorferi untergruppen, dafür kodierende gene sowie impfstoffe
EP0650527B1 (en) 1991-10-22 2003-03-12 Symbicom Ab Improvement in borrelia burgdorferi diagnosis and prophylaxis
US5776427A (en) 1992-03-05 1998-07-07 Board Of Regents, The University Of Texas System Methods for targeting the vasculature of solid tumors
FR2695563B1 (fr) * 1992-09-11 1994-12-02 Pasteur Institut Microparticules portant des antigènes et leur utilisation pour l'induction de réponses humorales ou cellulaires.
US6004763A (en) * 1992-09-11 1999-12-21 Institut Pasteur Antigen-carrying microparticles and their use in the induction of humoral or cellular responses
CA2196311A1 (en) 1994-08-19 1996-02-29 David H. Sachs Genetically engineered swine cells
AU2002327338A1 (en) * 2001-07-25 2003-02-17 New York University Use of glycosylceramides as adjuvants for vaccines against infections and cancer
DE10164309A1 (de) * 2001-12-28 2003-07-10 Fraunhofer Ges Forschung Verbesserte strukturiert-funktionale Bindematrices für Biomoleküle
US20070104726A1 (en) * 2002-08-14 2007-05-10 Avidis Sa Multimeric complexes of antigens and adjuvants
WO2004076677A2 (en) 2003-02-26 2004-09-10 Institute For Research In Biomedicine Monoclonal antibody production by ebv transformation of b cells
US20050175583A1 (en) * 2003-12-02 2005-08-11 Lawrence Tamarkin Methods and compositions for the production of monoclonal antibodies
JP4889485B2 (ja) 2004-06-11 2012-03-07 独立行政法人理化学研究所 調節性細胞リガンドをリポソームに含有させてなる医薬
ATE406874T1 (de) 2004-07-07 2008-09-15 Statens Seruminstitut Zusammensetzungen und verfahren zur stabilisierung von adjuvans-formulierungen auf lipid-basis unter verwendung von glykolipiden
WO2006037979A2 (en) * 2004-10-01 2006-04-13 Midatech Limited Nanoparticles comprising antigens and adjuvants and immunogenic structure
ATE438385T1 (de) * 2005-03-02 2009-08-15 Secr Defence Pharmazeutische zusammensetzung
CA2626997C (en) 2005-10-25 2014-12-23 Ludwig Institute For Cancer Research Analogs of alpha galactosylceramide and uses thereof
US20070231344A1 (en) 2005-10-28 2007-10-04 The Brigham And Women's Hospital, Inc. Conjugate vaccines for non-proteinaceous antigens
WO2007051004A2 (en) * 2005-10-28 2007-05-03 The Brigham And Women's Hospital, Inc. Conjugate vaccines for non-proteinaceous antigens
EP2288381A2 (en) * 2008-05-02 2011-03-02 Cancer Research Technology Limited Products and methods for stimulating an immune response
JP5782775B2 (ja) 2011-03-29 2015-09-24 ソニー株式会社 情報表示装置および情報表示方法、並びにプログラム

Also Published As

Publication number Publication date
AU2009241645A1 (en) 2009-11-05
EP2711020B1 (en) 2016-08-10
JP2015038066A (ja) 2015-02-26
EP2711021B1 (en) 2016-03-09
HK1161542A1 (zh) 2012-07-27
WO2009133378A2 (en) 2009-11-05
EP2711020A1 (en) 2014-03-26
CA2723226A1 (en) 2009-05-11
WO2009133378A3 (en) 2009-12-23
CN102170903A (zh) 2011-08-31
JP5853068B2 (ja) 2016-02-09
JP2011519847A (ja) 2011-07-14
JP5721620B2 (ja) 2015-05-20
EP2288381A2 (en) 2011-03-02
AU2009241645B2 (en) 2014-07-17
HK1191548A1 (zh) 2014-08-01
CN102170903B (zh) 2016-04-06
EP2711021A1 (en) 2014-03-26
JP2015028023A (ja) 2015-02-12
US20110280930A1 (en) 2011-11-17
ES2570973T3 (es) 2016-05-23

Similar Documents

Publication Publication Date Title
HK1191548A1 (zh) 用於刺激免疫反應的產品和方法
IL215292A0 (en) Compounds and methods for modulating an immune response
IL210677A0 (en) Method and assembly for three-diamensional products
GB0813709D0 (en) Method and product
EP2322672A4 (en) HEATING DEVICE AND HEATING METHOD
GB201102360D0 (en) Cooking apparatus and method
ZA201103050B (en) Systems and methods for providing products to animals
HK1150174A1 (zh) 免疫系統模擬裝置和方法
GB2472545B (en) System and methods for food processing
GB0819720D0 (en) Methods and products
EP2424990A4 (en) COMPOSITIONS AND METHODS FOR ENHANCING SPECIFIC IMMUNE RESPONSES OF ANTIGEN
GB0805473D0 (en) Method and article
HK1212698A1 (zh) 噻唑基和噁唑基異喹哪啶以及它們的使用方法
GB0812933D0 (en) Novel products and method
EP2155239A4 (en) METHOD FOR REDUCING IMMUNE RESPONSE AND TREATMENT OF IMMUNE DISEASES
EP2114416A4 (en) METHOD FOR TRIGGERING AN IMMUNE RESPONSE
EP2554239A4 (en) POWER-ON DEVICE AND POWER-UP METHOD
EP2498807A4 (en) COMPOSITION, METHODS, AND APPLICATIONS OF STIMULATION OF IMMUNE RESPONSES
GB2476767B (en) Method of modifying the immune response
GB201003082D0 (en) Heating apparatus and method
GB0921525D0 (en) Product and method
PL2186576T4 (pl) Sposób i urządzenie do sortowania produktów
GB0817710D0 (en) Method and device for the cooking of foodstuffs
EP2255823A4 (en) GUT IMMUNE-STIMULATOR
GB0803731D0 (en) Methods and products

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20200502